Glassman Wealth Services Ironwood Pharmaceuticals Inc Transaction History

Glassman Wealth Services

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$10.86 - $13.95 $162 - $209	-15 Reduced 8.15%	169 $2,000
Q3 2021 Nov 10, 2021	BUY	$11.92 - $13.92 $178 - $208	15 Added 8.88%	184 $2,000
Q3 2020 Nov 09, 2020	BUY	$8.99 - $10.74 $890 - $1,063	99 Added 141.43%	169 $2,000
Q1 2019 May 10, 2019	BUY	$8.27 - $12.73 $578 - $891	70 New	70 $1,000

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $541M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.